HIPEC: Its Place in the Treatment of Peritoneal Cancers

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an innovative approach to treating peritoneal cancers. It has the potential to increase patients' lifespan and quality of life by targeting microscopic cancer cells that remain in the abdominal cavity after surgery.

What is HIPEC?

HIPEC is a procedure performed after surgical resection where high-temperature chemotherapy is administered directly into the peritoneal cavity. Unlike conventional chemotherapy, this method is applied directly to the abdomen, allowing it to reach cancer cells more effectively. The high temperature enhances the potency of the drugs and strengthens their potential to eliminate microscopic cancer cells.

In Which Cancer Types Is It Used?

• Pseudomyxoma Peritonei

• Peritoneal Mesothelioma

• Peritoneal Metastases of Colorectal Cancer

• Ovarian Cancer

Advantages of HIPEC

1. Direct Effect: Applying chemotherapy drugs directly into the abdominal cavity reduces systemic side effects.

2. High Temperature: The heat plays an effective role in destroying cancer cells.

3. Long-Term Survival: HIPEC extends the lifespan in suitable patients.

Risks and Side Effects

As with any treatment method, HIPEC also has some risks, including infection, organ dysfunction, and chemotherapy-related side effects. However, these effects can be minimized with precautions taken during the treatment.

Conclusion

HIPEC is a promising method for the treatment of peritoneal cancers. With advanced technology and a multidisciplinary approach, this treatment can become more accessible to a wider range of patients. It is crucial for each patient to be evaluated individually when planning a treatment.